Confirmed Invited Speakers

A distinguished panel of world-renowned speakers have already confirmed their participation to the CLEPSO Meeting 2018:



Lucia ALTUCCI, University of Naples, Naples, Italy

From Single-Target to Multi-Target Epigenetic Therapeutics


Jesper Boje ANDERSEN, Univesity of Copenhagen, Copenhagen, Denmark

Epigenetics of Cholangiocarcinoma


Wim Van Den BERGHE, University of Antwerp, Belgium

BRCA Methylation Changes in Cancer and Cardiovascular Disease


Fabio COPPEDÈ, University of Pisa, Pisa, Italy

Pharmacoepigenetics and Pharmacoepigenomics of GastrointestinalCancers


Jim DAVIE, University of Manitoba, Winnipeg, Canada

Epigenetic Profiling of Fetal Alcohol Syndrome and Type II Diabetes


James D. FLANAGAN, Imperial College of London, London, UK

Epigenome-Wide Association Studies for Breast Cancer Risk and Risk Factors.


Kirsten Grønbæk, Copenhagen Biocenter, Copenhagen, Denmark

Modulation of the Immune System by Epigenetic Therapy


Christian HEDRICH, University of Liverpool, Liverpool, UK

On the Epigenetics of Systemic Lupus Erythematosus


Sam KEATING, Radboud Center for Infectious Diseases, Nijmegen, The Netherlands

Epigenetics and the Immune System


Vessela N. KRISTENSEN, University of Oslo, Oslo, Norway

DNA Methylation at Enhancers Identifies Distinct Breast Cancer Lineages.


Jonathan LICHT, University of Florida, Gainesville, FL, USA

Epigenetic Dysregulation in Lymphoid Malignancy


Charlotte LING, University of Lund, Malmö, Sweden

The Effects of High Glucose Exposure on Global Gene Expression and DNA Methylation in Human Pancreatic Islets.


Janos MINAROVITS, University of Szeged, Szeged, Hungary

Epigenetic Dysregulation Through Infectious Disease


Pamela MUNSTER, University of California, San Francisco CA, USA

Select HDAC Enzyme Expression as Host Specific Biomarkers


Arpad PATAI, Semmelweis University, Budapest, Hungary

Clinical Implications of DNA Methylation in Inflammatory Bowel Disease, Colorectal Polyps and Cancer


Gerd PFEIFER, Cancer for Epigenetics, Van Andel Research Institute, Grand Rapids, MI, USA

Oxidation of 5-Methylcytosine in Development and Disease


Edyta RESZKA, Department of Toxicology and Carcinogenesis, Nofer Institute of Occupational Diseases, Lodz, Poland

Circadian Gene Variants and Breast Cancer.


Bart P.F. RUTTEN, Maastricht University Medical Centre, Maastricht, the Netherlands

On the Epigenetics of Aging, Neurodegeneration and Brain Cancer


David S. SCHRUMP, NIH, Bethesda, MD, USA

Epigenetics of Malignant Pleural Mesothelioma


Anton SHOSTAK, University of Heidelberg, Heidelberg, Germany

Circadian Clock, Cell Division, and Cancer: From Molecules to Organism.


Alessio SQUASSINA, University of Cagliari, Cagliari, Italy

Recent Trends on the Role of Epigenomics and Noncoding RNAs in Mood Stabilizing Treatment


Henk STUNNENBERG, Nijmegen Centre for Molecular Life Sciences, Nijmegen, The Netherlands

The Interplay of Epigenetic Marks During Stem Cell Differentiation and Development.